journal article·2026-06-12

Silica-Gold Nanocomposites Enhance Uptake and Radiosensitization in Prostate Cancer Cell Models

Zengchun Xie, Mukesh K. Kumawat, Robert M. Lees, Laura Zanetti-Domingues, Stanley W. Botchway, Jonathan A. Coulter, Susan J. Quinn

ACS Applied Nano Materials· Volume 9· Issue 23
Publisher page

Abstract

Gold nanoparticles (AuNPs) are promising high atomic number ( high-Z ) radiosensitizers but clinical translation is limited by efficient tumor cell delivery. Here the design and evaluation of gold nanocomposite (NC) architectures to transport high concentrations of AuNPs into prostate cancer cells at an increased internalization rate is reported. Gold NCs (∼50 nm) comprising a silica nanoparticle scaffold were reproducibly synthesized with excellent colloidal stability over several weeks. Efficient NC internalization by prostate cancer PC3 and DU145 cells was confirmed by hyperspectral imaging, fluorescence lifetime microscopy, multiphoton microscopy, and focused ion beam scanning electron microscopy (FIB/SEM). Au/SiAuC NCs comprising 4 nm AuNPs immobilized on silica-coated 20 nm AuNP cores achieved the highest intracellular gold accumulation (PC3: 38 pg/cell; DU145: 40 pg/cell). Critically, the rate of NC gold uptake was significantly faster (14.6 ± 1.98 pg Au/cell/h) than free AuNPs (3.1 ± 1.5 pg Au/cell/h), a property that minimizes the risk of off-target effects. Toxicity studies confirmed that NCs were well tolerated, inducing no significant direct toxicity. Upon irradiation, Au/SiAuC NCs yielded a significant sensitizer enhancement ratio (SER) of 1.34 ( p < 0.05) and a dose-dependent increase in cell death, underpinned by enhanced NC-mediated DNA damage. The combination of high cellular uptake, low intrinsic cytotoxicity, and effective radiosensitization supports the application of this platform in nanomedicine-based radiotherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Radiation Therapy and Dosimetry · Nanoplatforms for cancer theranostics · Effects of Radiation Exposure

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemistry

University College Dublin

School of Pharmacy

Queen’s University Belfast

STFC Central Laser Facility, Research Complex at Harwell

Rutherford Appleton Laboratory

Funding

Science Foundation Ireland · Science and Technology Facilities Council · Higher Education Authority

References (45)

Show source-provided references
1. 10.1259/bjr.2023033410.1259/bjr.20230334 ↗
2. 10.1038/nrclinonc.2012.20310.1038/nrclinonc.2012.203 ↗
3. 10.1002/1878-0261.1269010.1002/1878-0261.12690 ↗
4. 10.1186/1471-2490-13-410.1186/1471-2490-13-4 ↗
5. 10.1016/j.pharmthera.2015.06.00610.1016/j.pharmthera.2015.06.006 ↗
6. 10.1016/j.tranon.2016.01.00210.1016/j.tranon.2016.01.002 ↗
7. 10.1002/ijc.2859510.1002/ijc.28595 ↗
8. 10.1158/1078-0432.CCR-16-129710.1158/1078-0432.CCR-16-1297 ↗
9. 10.1016/j.ijrobp.2010.08.04410.1016/j.ijrobp.2010.08.044 ↗
10. 10.3390/ijms2102042910.3390/ijms21020429 ↗
11. 10.1021/acsami.0c1654810.1021/acsami.0c16548 ↗
12. 10.1186/s12645-017-0026-010.1186/s12645-017-0026-0 ↗
13. 10.1007/s00066-024-02301-y10.1007/s00066-024-02301-y ↗
14. 10.1016/j.pbiomolbio.2022.08.00610.1016/j.pbiomolbio.2022.08.006 ↗
15. 10.1002/smll.20140011010.1002/smll.201400110 ↗
16. 10.1016/j.radonc.2011.08.02610.1016/j.radonc.2011.08.026 ↗
17. 10.1016/j.ejmp.2020.09.02210.1016/j.ejmp.2020.09.022 ↗
18. 10.1016/j.bbagen.2023.13031810.1016/j.bbagen.2023.130318 ↗
19. 10.1038/srep0001810.1038/srep00018 ↗
20. 10.1016/j.ijrobp.2015.09.03210.1016/j.ijrobp.2015.09.032 ↗
21. 10.1038/s41598-017-04229-z10.1038/s41598-017-04229-z ↗
22. 10.2147/IJN.S21400810.2147/IJN.S214008 ↗
23. 10.1021/nl052396o10.1021/nl052396o ↗
24. 10.1088/0957-4484/27/45/45510110.1088/0957-4484/27/45/455101 ↗
25. 10.1016/j.biomaterials.2012.05.04710.1016/j.biomaterials.2012.05.047 ↗
26. 10.1211/jpp.60.8.000510.1211/jpp.60.8.0005 ↗
27. 10.1039/C6CC07947D10.1039/C6CC07947D ↗
28. 10.1021/acsanm.0c0041310.1021/acsanm.0c00413 ↗
29. 10.1038/s41598-019-50332-810.1038/s41598-019-50332-8 ↗
30. 10.1039/D1NR04582B10.1039/D1NR04582B ↗
31. 10.1039/C3TC31171F10.1039/C3TC31171F ↗
32. 10.1259/bjr.2015017010.1259/bjr.20150170 ↗
33. 10.1111/jmi.1221810.1111/jmi.12218 ↗
34. 10.1016/0021-9797(68)90272-510.1016/0021-9797(68)90272-5 ↗
35. 10.1021/la201938u10.1021/la201938u ↗
36. 10.1039/C9NR05014K10.1039/C9NR05014K ↗
37. 10.1016/j.addr.2011.02.00110.1016/j.addr.2011.02.001 ↗
38. 10.1016/j.scitotenv.2021.14547810.1016/j.scitotenv.2021.145478 ↗
39. 10.1016/j.biomaterials.2015.03.00110.1016/j.biomaterials.2015.03.001 ↗
40. 10.1038/s41598-022-13368-x10.1038/s41598-022-13368-x ↗
41. 10.3390/ijms2405492010.3390/ijms24054920 ↗
42. 10.1667/RR1984.110.1667/RR1984.1 ↗
43. 10.1016/j.radonc.2013.12.01310.1016/j.radonc.2013.12.013 ↗
44. 10.3390/molecules3005103810.3390/molecules30051038 ↗
45. 10.1038/srep1944210.1038/srep19442 ↗